Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Virus Linked to Development of Common Form of Skin Cancer

By LabMedica International staff writers
Posted on 11 Aug 2009
Cancer researchers have linked a virus implicated in the development of a rare, deadly form of skin cancer to the much more common and treatable type of skin cancer, squamous cell carcinoma (SCC).

Investigators from Ohio State University (Columbus, USA) had speculated that the Merkel cell polyomavirus (MCPyV), which could be isolated from patients with the relatively rare skin cancer Merkel cell carcinoma, might also play a role in the development of the milder and more common SCC. More...
To test this hypothesis the investigators used polymerase chain reaction (PCR) with primer sets directed against the large T (LT) antigen and VP1 gene of MCPyV.

The investigators reported in the June 25, 2009, online edition of the Journal of Investigative Dermatology that they had detected MCPyV in 15% (26/177) of SCC DNA samples and 17% (11/63) of adjacent skin DNA samples from 21 of 58 (36%) individuals studied. They did not detect MCPyV in any matched normal blood DNA (0/57), but observed the presence of MCPyV DNA in one of 12 normal mouthwash DNAs. All sequenced SCC samples had a common mutation that shortened the LT antigen, which provided indirect evidence of viral integration into the cancer cells.

"This is indirect evidence that the virus might play a role in causing some cases of squamous cell carcinoma,” said senior author Dr. Amanda E. Toland, assistant professor of molecular virology, immunology, and medical genetics at Ohio State University. "Originally it was thought that this virus caused only this rare skin cancer, but our findings indicate that it is a lot more prevalent than we initially thought. That suggests that the virus may develop a mutation that causes it to integrate into host-cell DNA, and therefore, may play a role in causing the cancer. If it proves to be a cancer-causing virus, and if it proves to be common in the general population, it might be something we should begin screening people for.”

Related Links:
Ohio State University



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.